US approves maternal vaccine to prevent RSV in infants

[Article] Pfizer obtient l'aval de la FDA pour un vaccin maternel contre le VRS.


Profitez de la lecture automatique avec accent avec un abonnement

US approves maternal vaccine to prevent RSV in infants.Washington (AFP) - The United States on Monday became the first country to approve a vaccine for pregnant women that prevents severe disease caused by Respiratory Syncytial Virus (RSV) in their babies.The Pfizer shot, which was already approved for...
This article was published Wednesday, 23 August, 2023 by AFP
Article complet réservé aux abonnés.
Accédez à l'intégralité de l'article, choisissez un abonnement
d4f063a1c8cd171cc83532d44d41c2eccd108efb.jpg

The Pfizer shot, which was already approved for use in older adults, has now been greenlighted for use as a single injection 32 through 36 weeks of pregnancy, to protect infants from birth through six months © GETTY IMAGES NORTH AMERICA/AFP/File SPENCER PLATT


Plus d'articles